clavuxan (co-amoxiclav) is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1):

• severe infections of the ear, nose and throat (such as mastoiditis, peritonsillar infections, epiglottitis and sinusitis when accompanied by severe systemic signs and symptoms)
• acute exacerbations of chronic bronchitis (adequately diagnosed)
• community acquired pneumonia
• cystitis
• pyelonephritis
• skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.
• bone and joint infections, in particular osteomyelitis
• intra-abdominal infections
• female genital infections

prophylaxis against infections associated with major surgical procedures in adults, such as those involving the:

• gastrointestinal tract
• pelvic cavity
• head and neck
• biliary tract surgery

consideration should be given to the official guidance on the appropriate use of antibacterial agents.

.

.

clavuxan (co-amoxiclav) is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1):

• severe infections of the ear, nose and throat (such as mastoiditis, peritonsillar infections, epiglottitis and sinusitis when accompanied by severe systemic signs and symptoms)
• acute exacerbations of chronic bronchitis (adequately diagnosed)
• community acquired pneumonia
• cystitis
• pyelonephritis
• skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.
• bone and joint infections, in particular osteomyelitis
• intra-abdominal infections
• female genital infections

prophylaxis against infections associated with major surgical procedures in adults, such as those involving the:

• gastrointestinal tract
• pelvic cavity
• head and neck
• biliary tract surgery

consideration should be given to the official guidance on the appropriate use of antibacterial agents.

.

.